OTCMKTS:DSKX

DS Healthcare Group Competitors

$0.0020
0.00 (0.00 %)
(As of 06/12/2019)
Add
Compare
Today's Range
$0.00
Now: $0.00
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00
$0.09
Volume25 shs
Average Volume5,741 shs
Market Capitalization$60,378.00
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

DS Healthcare Group (OTCMKTS:DSKX) Vs. EL, CL, NTCO, COTY, IPAR, and EPC

Should you be buying DSKX stock or one of its competitors? Companies in the industry of "toilet preparations" are considered alternatives and competitors to DS Healthcare Group, including The Estée Lauder Companies (EL), Colgate-Palmolive (CL), Natura &Co (NTCO), Coty (COTY), Inter Parfums (IPAR), and Edgewell Personal Care (EPC).

The Estée Lauder Companies (NYSE:EL) and DS Healthcare Group (OTCMKTS:DSKX) are both consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations.

Institutional and Insider Ownership

55.0% of The Estée Lauder Companies shares are owned by institutional investors. 14.0% of The Estée Lauder Companies shares are owned by insiders. Comparatively, 19.4% of DS Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and target prices for The Estée Lauder Companies and DS Healthcare Group, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
The Estée Lauder Companies041502.79
DS Healthcare Group0000N/A

The Estée Lauder Companies presently has a consensus target price of $281.0952, suggesting a potential downside of 6.96%. Given The Estée Lauder Companies' higher possible upside, research analysts plainly believe The Estée Lauder Companies is more favorable than DS Healthcare Group.

Earnings and Valuation

This table compares The Estée Lauder Companies and DS Healthcare Group's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Estée Lauder Companies$14.29 billion7.67$684 million$4.1273.33
DS Healthcare GroupN/AN/AN/AN/AN/A

The Estée Lauder Companies has higher revenue and earnings than DS Healthcare Group.

Profitability

This table compares The Estée Lauder Companies and DS Healthcare Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
The Estée Lauder Companies4.38%32.72%7.91%
DS Healthcare GroupN/AN/AN/A

Summary

The Estée Lauder Companies beats DS Healthcare Group on 7 of the 8 factors compared between the two stocks.

Colgate-Palmolive (NYSE:CL) and DS Healthcare Group (OTCMKTS:DSKX) are both consumer staples companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, earnings and analyst recommendations.

Earnings and Valuation

This table compares Colgate-Palmolive and DS Healthcare Group's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Colgate-Palmolive$15.69 billion4.31$2.37 billion$2.8328.19
DS Healthcare GroupN/AN/AN/AN/AN/A

Colgate-Palmolive has higher revenue and earnings than DS Healthcare Group.

Profitability

This table compares Colgate-Palmolive and DS Healthcare Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Colgate-Palmolive16.65%383.88%17.10%
DS Healthcare GroupN/AN/AN/A

Institutional and Insider Ownership

76.5% of Colgate-Palmolive shares are owned by institutional investors. 0.8% of Colgate-Palmolive shares are owned by insiders. Comparatively, 19.4% of DS Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and target prices for Colgate-Palmolive and DS Healthcare Group, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Colgate-Palmolive26202.00
DS Healthcare Group0000N/A

Colgate-Palmolive presently has a consensus target price of $81.9091, suggesting a potential upside of 2.67%. Given Colgate-Palmolive's higher possible upside, research analysts plainly believe Colgate-Palmolive is more favorable than DS Healthcare Group.

Summary

Colgate-Palmolive beats DS Healthcare Group on 7 of the 8 factors compared between the two stocks.

Natura &Co (NYSE:NTCO) and DS Healthcare Group (OTCMKTS:DSKX) are both consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, analyst recommendations and earnings.

Earnings & Valuation

This table compares Natura &Co and DS Healthcare Group's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Natura &Co$3.66 billion3.37$39.40 million$0.09199.11
DS Healthcare GroupN/AN/AN/AN/AN/A

Natura &Co has higher revenue and earnings than DS Healthcare Group.

Profitability

This table compares Natura &Co and DS Healthcare Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Natura &CoN/AN/AN/A
DS Healthcare GroupN/AN/AN/A

Institutional & Insider Ownership

4.8% of Natura &Co shares are owned by institutional investors. 19.4% of DS Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings and price targets for Natura &Co and DS Healthcare Group, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Natura &Co10001.00
DS Healthcare Group0000N/A

Summary

Natura &Co beats DS Healthcare Group on 2 of the 3 factors compared between the two stocks.

Coty (NYSE:COTY) and DS Healthcare Group (OTCMKTS:DSKX) are both consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, analyst recommendations and earnings.

Earnings & Valuation

This table compares Coty and DS Healthcare Group's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Coty$4.72 billion1.41$-1,006,700,000.00($0.48)-18.06
DS Healthcare GroupN/AN/AN/AN/AN/A

DS Healthcare Group has lower revenue, but higher earnings than Coty.

Profitability

This table compares Coty and DS Healthcare Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Coty-15.56%-3.35%-0.72%
DS Healthcare GroupN/AN/AN/A

Institutional & Insider Ownership

22.7% of Coty shares are owned by institutional investors. 1.9% of Coty shares are owned by insiders. Comparatively, 19.4% of DS Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings and price targets for Coty and DS Healthcare Group, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Coty18502.29
DS Healthcare Group0000N/A

Coty presently has a consensus target price of $6.6875, suggesting a potential downside of 22.87%. Given Coty's higher possible upside, equities analysts clearly believe Coty is more favorable than DS Healthcare Group.

Inter Parfums (NASDAQ:IPAR) and DS Healthcare Group (OTCMKTS:DSKX) are both consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, analyst recommendations and earnings.

Earnings & Valuation

This table compares Inter Parfums and DS Healthcare Group's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inter Parfums$713.51 million3.16$60.25 million$1.9037.55
DS Healthcare GroupN/AN/AN/AN/AN/A

Inter Parfums has higher revenue and earnings than DS Healthcare Group.

Profitability

This table compares Inter Parfums and DS Healthcare Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Inter Parfums5.94%5.12%3.98%
DS Healthcare GroupN/AN/AN/A

Institutional & Insider Ownership

53.1% of Inter Parfums shares are owned by institutional investors. 44.7% of Inter Parfums shares are owned by insiders. Comparatively, 19.4% of DS Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings and price targets for Inter Parfums and DS Healthcare Group, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Inter Parfums05102.17
DS Healthcare Group0000N/A

Inter Parfums presently has a consensus target price of $62.50, suggesting a potential downside of 12.40%. Given Inter Parfums' higher possible upside, equities analysts clearly believe Inter Parfums is more favorable than DS Healthcare Group.

Summary

Inter Parfums beats DS Healthcare Group on 8 of the 8 factors compared between the two stocks.

Edgewell Personal Care (NYSE:EPC) and DS Healthcare Group (OTCMKTS:DSKX) are both consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, dividends, institutional ownership, analyst recommendations and earnings.

Analyst Ratings

This is a summary of recent ratings and price targets for Edgewell Personal Care and DS Healthcare Group, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Edgewell Personal Care13102.00
DS Healthcare Group0000N/A

Edgewell Personal Care presently has a consensus target price of $35.20, suggesting a potential downside of 8.78%. Given Edgewell Personal Care's higher possible upside, equities analysts clearly believe Edgewell Personal Care is more favorable than DS Healthcare Group.

Institutional & Insider Ownership

92.3% of Edgewell Personal Care shares are owned by institutional investors. 1.0% of Edgewell Personal Care shares are owned by insiders. Comparatively, 19.4% of DS Healthcare Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Edgewell Personal Care and DS Healthcare Group's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Edgewell Personal Care$1.95 billion1.07$67.60 million$2.7314.14
DS Healthcare GroupN/AN/AN/AN/AN/A

Edgewell Personal Care has higher revenue and earnings than DS Healthcare Group.

Profitability

This table compares Edgewell Personal Care and DS Healthcare Group's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Edgewell Personal Care3.47%10.83%4.37%
DS Healthcare GroupN/AN/AN/A

Summary

Edgewell Personal Care beats DS Healthcare Group on 7 of the 8 factors compared between the two stocks.


DS Healthcare Group Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
The Estée Lauder Companies logo
EL
The Estée Lauder Companies
2.1$302.12flat$109.60 billion$14.29 billion184.22Analyst Report
Colgate-Palmolive logo
CL
Colgate-Palmolive
2.0$79.78flat$67.62 billion$15.69 billion25.49
Natura &Co logo
NTCO
Natura &Co
0.1$17.92flat$12.33 billion$3.66 billion199.11
Coty logo
COTY
Coty
1.2$8.67flat$6.65 billion$4.72 billion-7.47
Inter Parfums logo
IPAR
Inter Parfums
1.6$71.35flat$2.26 billion$713.51 million71.35
Edgewell Personal Care logo
EPC
Edgewell Personal Care
1.7$38.59flat$2.09 billion$1.95 billion31.12Gap Down
e.l.f. Beauty logo
ELF
e.l.f. Beauty
1.3$27.85flat$1.43 billion$282.85 million146.59
Mandom logo
MDOMF
Mandom
0.5$24.55flat$1.19 billion$752.29 million27.28Analyst Downgrade
Analyst Revision
News Coverage
Revlon logo
REV
Revlon
0.9$11.09flat$583.33 million$2.42 billion-1.65Gap Down
UG
United-Guardian
1.0$14.89flat$68.35 million$13.60 million16.54
ETFM
FOMO
0.5$0.01flat$54.98 millionN/A0.00Gap Down
CAWW
CCA Industries
1.0$2.25flat$16.79 million$17.14 million-112.50High Trading Volume
Gap Down
ASCBQ
Ascendia Brands
0.2$0.00flat$0.00N/A0.00
NXRA
Nextera Enterprises
0.0$0.00flat$0.00N/A0.00
This page was last updated on 4/10/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.